Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients

被引:33
|
作者
Ishida, Hidekazu [1 ]
Kogaki, Shigetoyo [1 ]
Ichimori, Hiroaki [1 ]
Narita, Jun [1 ]
Nawa, Nobutoshi [1 ]
Ueno, Takayoshi [2 ]
Takahashi, Kunihiko [3 ,7 ]
Kayatani, Futoshi [3 ,7 ]
Kishimoto, Hidehumi [4 ,7 ]
Nakayama, Masahiro [5 ,7 ]
Sawa, Yoshiki [2 ]
Beghetti, Maurice [6 ]
Ozono, Keiichi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan
[3] Osaka Med Ctr, Dept Pediat Cardiol, Osaka, Japan
[4] Osaka Med Ctr, Dept Pediat Cardiac Surg, Osaka, Japan
[5] Osaka Med Ctr, Dept Clin Lab Med & Anat Pathol, Osaka, Japan
[6] Childrens Univ Hosp Geneva, Pediat Cardiol Unit, Geneva, Switzerland
[7] Res Inst Maternal & Child Hlth, Osaka, Japan
关键词
Endothelin-1; Endothelin receptor; Immunohistochemistry; Fontan procedure; HISTOMORPHOMETRIC ANALYSIS; HYPERTENSION; BOSENTAN; MORTALITY; SELECTION; THERAPY; ERA;
D O I
10.1016/j.ijcard.2011.02.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endothelin-1 (ET-1), a potent vasoconstrictor, is considered to be implicated in failing Fontan circulation, however the expressions of ET-1 and endothelin receptor type A (ETAR) and type B (ETBR) in the pulmonary arteries of failed Fontan patients were not elucidated. Methods: Immunohistochemistry and quantitative real-time PCR were used to analyse the expression levels of ET-1 and its receptors in the pulmonary arteries of the autopsy lung tissues of the patients who died after the Fontan procedure (n = 10). We divided these patients into 3 groups, failed Fontan (n = 4), heart failure (n = 3) and non-failed Fontan (n = 3), and then compared those to the age-matched normal controls (n = 4). Results: The intra-acinar pulmonary arteries of failed Fontan patients showed significant medial hypertrophy. Computational optical density analyses of the immunostaining revealed that the expressions of ET-1, ETAR, and ETBR in the intra-acinar pulmonary arteries were significantly increased in the failed Fontan patients (P<0.05 vs. normal controls), however no significant difference was observed between the non-failed Fontan patients and the normal controls. Quantitative real-time PCR analyses confirmed that the mRNA expressions of ET-1, ETAR, and ETBR were significantly increased in the failed Fontan patients (P<0.05 vs. normal controls). Conclusion: The overexpression of ET-1 and its receptors in the pulmonary arteries can cause pulmonary vasoconstriction and vascular remodelling, leading to failed Fontan circulation. This study suggests a histopathological rationale for the potential benefits of endothelin receptor antagonists in patients with failing Fontan circulation. (c) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 50 条
  • [41] Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure
    Zolk, O
    Quattek, J
    Sitzler, G
    Schrader, T
    Nickenig, G
    Schnabel, P
    Shimada, K
    Takahashi, M
    Böhm, M
    CIRCULATION, 1999, 99 (16) : 2118 - 2123
  • [42] Endothelin-1 modulation of cAMP in rat pulmonary arteries: Effect of chronic hypoxia
    Mullaney, I
    Vaughan, DM
    MacLean, MM
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S112 - S114
  • [43] Clinical and prognostic value of endothelin-1 and big endothelin-1 expression in children with pulmonary hypertension
    Latus, Heiner
    Karanatsios, Georg
    Basan, Ulrike
    Salser, Kirstin
    Mueller, Simon
    Khalil, Markus
    Kreuder, Joachim
    Schranz, Dietmar
    Apitz, Christian
    HEART, 2016, 102 (13) : 1052 - 1058
  • [44] Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension
    Rubens, C
    Ewert, R
    Halank, M
    Wensel, R
    Orzechowski, HD
    Schultheiss, HP
    Hoeffken, G
    CHEST, 2001, 120 (05) : 1562 - 1569
  • [45] PLASMA-LEVELS OF ENDOTHELIN-1, BIG ENDOTHELIN-1 AND ENDOTHELIN-3 IN HEMODIALYSIS-PATIENTS
    MIYAUCHI, T
    KURIHARA, T
    YAMAGUCHI, I
    SUGISHITA, Y
    SUZUKI, N
    MATSUMOTO, H
    GOTO, K
    MASAKI, T
    CIRCULATION, 1990, 82 (04) : 14 - 14
  • [46] Time course of endothelin-1 and adrenomedullin after the Fontan procedure
    Hiramatsu, T
    Imai, Y
    Takanashi, Y
    Seo, K
    Terada, M
    Aoki, M
    Nakazawa, M
    ANNALS OF THORACIC SURGERY, 1999, 68 (01): : 169 - 172
  • [47] EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION
    GIAID, A
    YANAGISAWA, M
    LANGLEBEN, D
    MICHEL, RP
    LEVY, R
    SHENNIB, H
    KIMURA, S
    MASAKI, T
    DUGUID, WP
    STEWART, DJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24): : 1732 - 1739
  • [48] ENDOTHELIN-1 RECEPTORS IN RAT RENAL GLOMERULI
    ORITA, Y
    FUJIWARA, Y
    OCHI, S
    TAKAMA, T
    FUKUNAGA, M
    YOKOYAMA, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 : S159 - S161
  • [49] Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis
    Peri, A
    Fantoni, G
    Granchi, S
    Vannelli, GB
    Barni, T
    Amerini, S
    Pupilli, C
    Barbagli, G
    Forti, G
    Serio, M
    Maggi, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11): : 3797 - 3806
  • [50] GENE-EXPRESSION OF ENDOTHELIN ISOFORMS AND RECEPTORS IN ENDOTHELIN-1 KNOCKOUT MICE
    MAEMURA, K
    KURIHARA, H
    KURIHARA, Y
    KUWAKI, T
    KUMADA, M
    YAZAKI, Y
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 : S17 - S21